Astrana Health, Inc.
DE ˙ DB ˙ US03763A2078
31,40 € ↑0,20 (0,64%)
2026-06-04
AKTIENPREIS
SecurityDE:3AM / Astrana Health, Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership438,163 shares
Latest Disclosed Value $ 10,743,758
Northern Trust Corp reports 8.87% increase in ownership of 3AM / Astrana Health, Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 438,163 shares of Astrana Health, Inc. (DE:3AM) valued at $9,113,790 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 402,463 shares of Astrana Health, Inc.. This represents a change in shares of 8.87% during the quarter. The current value of the position is $13,758,318 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ASTRANA HEALTH COM NEW 03763A207 438,163 35,700 8.87 10,744 7.59 0.0003
2026-02-17 2025-12-31 13F ASTRANA HEALTH COM NEW 03763A207 402,463 -20,786 -4.91 9,985 -16.78 0.0013
2025-11-14 2025-09-30 13F ASTRANA HEALTH COM NEW 03763A207 423,249 -11,219 -2.58 11,999 11.01 0.0015
2025-08-13 2025-06-30 13F ASTRANA HEALTH COM NEW 03763A207 434,468 -26,334 -5.71 10,810 -24.35 0.0015
2025-05-13 2025-03-31 13F ASTRANA HEALTH COM NEW 03763A207 460,802 -6,377 -1.37 14,289 -2.99 0.0021
2025-02-14 2024-12-31 13F ASTRANA HEALTH COM NEW 03763A207 467,179 43,032 10.15 14,730 -40.06 0.0021
2024-11-13 2024-09-30 13F ASTRANA HEALTH COM 03763A207 424,147 -2,239 -0.53 24,575 42.10 0.0040
2024-08-14 2024-06-30 13F ASTRANA HEALTH COM 03763A207 426,386 -21,008 -4.70 17,294 -7.94 0.0029
2024-05-14 2024-03-31 13F ASTRANA HEALTH COM 03763A207 447,394 -5,338 -1.18 18,786 8.35 0.0032
2024-02-13 2023-12-31 13F APOLLO MED HLDGS COM 03763A207 452,732 -14,774 -3.16 17,340 20.23 0.0031
2023-11-13 2023-09-30 13F APOLLO MED HLDGS COM 03763A207 467,506 4,285 0.93 14,423 -1.47 0.0028
2023-08-11 2023-06-30 13F APOLLO MED HLDGS COM 03763A207 463,221 30,699 7.10 14,638 -7.21 0.0028
2023-05-15 2023-03-31 13F APOLLO MED HLDGS COM 03763A207 432,522 9,628 2.28 15,774 26.06 0.0031
2023-02-13 2022-12-31 13F APOLLO MED HLDGS COM 03763A207 422,894 12,104 2.95 12,513 -21.90 0.0026
2022-11-14 2022-09-30 13F APOLLO MED HLDGS COM 03763A207 410,790 2,974 0.73 16,021 1.80 0.0037
2022-08-12 2022-06-30 13F APOLLO MED HLDGS COM 03763A207 407,816 2,565 0.63 15,737 -19.88 0.0034
2022-05-13 2022-03-31 13F APOLLO MED HLDGS COM 03763A207 405,251 -16,675 -3.95 19,643 -36.64 0.0035
2022-02-08 2021-12-31 13F APOLLO MED HLDGS COM 03763A207 421,926 -3,741 -0.88 31,003 -20.01 0.0051
2021-11-15 2021-09-30 13F APOLLO MED HLDGS COM 03763A207 425,667 54,979 14.83 38,757 66.46 0.0069
2021-08-13 2021-06-30 13F APOLLO MED HLDGS COM NEW 03763A207 370,688 125,891 51.43 23,283 251.07 0.0041
2021-05-12 2021-03-31 13F APOLLO MED HLDGS COM NEW 03763A207 244,797 -20,051 -7.57 6,632 37.05 0.0012
2021-02-11 2020-12-31 13F APOLLO MED HLDGS COM NEW 03763A207 264,848 -6,653 -2.45 4,839 -0.68 0.0009
2020-11-16 2020-09-30 13F APOLLO MED HLDGS COM NEW 03763A207 271,501 68,159 33.52 4,872 45.22 0.0011
2020-08-14 2020-06-30 13F APOLLO MED HLDGS COM 03763A207 203,342 53 0.03 3,355 27.71 0.0008
2020-05-14 2020-03-31 13F APOLLO MED HLDGS COM NEW 03763A207 203,289 47,260 30.29 2,627 -8.56 0.0008
2020-02-14 2019-12-31 13F APOLLO MEDICAL HLDGS COM 03763A207 156,029 -183,375 -54.03 2,873 -51.96 0.0006
2019-11-13 2019-09-30 13F APOLLO MEDICAL HLDGS COM 03763A207 339,404 223,273 192.26 5,980 208.25 0.0014
2019-08-13 2019-06-30 13F APOLLO MEDICAL HLDGS COM 03763A207 116,131 -2,333 -1.97 1,940 -10.64 0.0005
2019-05-13 2019-03-31 13F APOLLO MEDICAL HLDGS COM NEW 03763A207 118,464 6,581 5.88 2,171 -2.25 0.0005
2019-02-12 2018-12-31 13F APOLLO MEDICAL HLDGS COM NEW 03763A207 111,883 27,894 33.21 2,221 19.80 0.0006
2018-11-14 2018-09-30 13F APOLLO MEDICAL HLDGS COM NEW 03763A207 83,989 -153,306 -64.61 1,854 -69.79 0.0005
2018-09-18 2018-06-30 13F/A-1 APOLLO MEDICAL HLDGS COM NEW 03763A207 237,295 237,295 6,137 0.0016
2018-08-14 2018-06-30 13F APOLLO MEDICAL HLDGS COM 03763A207 224,428 5,804 0.0015
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.